Waystar completed the acquisition of Iodine Software from Advent for $1.25bn.

Waystar, a provider of healthcare payment software, completed the acquisition of Iodine Software, an AI-powered clinical intelligence, from Advent, a private equity firm, for $1.25bn. "Iodine joining Waystar brings together comprehensive clinical and financial intelligence on a single AI-powered platform — a unique differentiator in the market. This further powers automation in the revenue cycle, strengthens financial performance, and leverages combined data assets to drive a continuously learning AI platform that maximizes client outcomes." Matt Hawkins, Waystar CEO.